Date published: 2025-12-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

PRL-3 Antibody (111AT714): sc-130245

4.0(1)
Write a reviewAsk a question

Datasheets
  • PRL-3 Antibody (111AT714) is a mouse monoclonal IgG1, cited in 1 publications, provided at 100 µg/ml
  • raised against recombinant PRL-3 of human origin
  • recommended for detection of PRL-3 of mouse, rat and human origin by WB, IP and ELISA
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for PRL-3 Antibody (111AT714). This work is in progress.

QUICK LINKS

SEE ALSO...

PRL-3 Antibody (111AT714) is a mouse monoclonal IgG1 antibody that detects PRL-3 in mouse, rat, and human samples through applications such as western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). Anti-PRL-3 antibody (111AT714) is available in a non-conjugated form, allowing for versatile experimental use. PRL-3, also known as Protein Tyrosine Phosphatase Type IVA, member 3 (PTP4A3), plays a critical role in cellular signaling pathways, particularly in cancer progression. PRL-3 is primarily localized to the cell plasma membrane and is expressed in various tissues, including heart, skeletal muscle, and epithelial cells of the small intestine. PRL-3′s membrane association facilitates interactions with other signaling molecules, thereby influencing processes such as cell growth and migration. Notably, overexpression of PRL-3 has been linked to enhanced cell proliferation and metastasis in colorectal cancer, making PRL-3 a potential therapeutic target for intervention in cancer treatment. PRL-3′s ability to inhibit angiotensin-II induced calcium mobilization further underscores PRL-3′s importance in regulating cellular responses. With diverse applications and critical role in cancer biology, PRL-3 monoclonal antibody (111AT714) serves as an essential tool for researchers investigating the mechanisms of tumorigenesis and metastasis.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

PRL-3 Antibody (111AT714) References:

  1. PRL-3 phosphatase and cancer metastasis.  |  Al-Aidaroos, AQ. and Zeng, Q. 2010. J Cell Biochem. 111: 1087-98. PMID: 21053359
  2. PRL-3, an emerging marker of carcinogenesis, is strongly associated with poor prognosis.  |  Guzińska-Ustymowicz, K. and Pryczynicz, A. 2011. Anticancer Agents Med Chem. 11: 99-108. PMID: 21291404
  3. PRL-3 activates mTORC1 in Cancer Progression.  |  Ye, Z., et al. 2015. Sci Rep. 5: 17046. PMID: 26597054
  4. Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3.  |  Rubio, T. and Köhn, M. 2016. Biochem Soc Trans. 44: 1305-1312. PMID: 27911713
  5. PRL-3 promotes telomere deprotection and chromosomal instability.  |  Lian, S., et al. 2017. Nucleic Acids Res. 45: 6546-6571. PMID: 28482095
  6. PRL-3 promotes breast cancer progression by downregulating p14ARF-mediated p53 expression.  |  Xie, H. and Wang, H. 2018. Oncol Lett. 15: 2795-2800. PMID: 29435006
  7. The Phosphatase PRL-3 Is Involved in Key Steps of Cancer Metastasis.  |  Duciel, L., et al. 2019. J Mol Biol. 431: 3056-3067. PMID: 31207239
  8. PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK.  |  Zhou, Q., et al. 2020. Theranostics. 10: 10345-10359. PMID: 32929353
  9. PRL-3 induces a positive signaling circuit between glycolysis and activation of STAT1/2.  |  Vandsemb, EN., et al. 2021. FEBS J. 288: 6700-6715. PMID: 34092011
  10. PRL-3 dephosphorylates p38 MAPK to promote cell survival under stress.  |  Shi, Y., et al. 2021. Free Radic Biol Med. 177: 72-87. PMID: 34662712

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PRL-3 Antibody (111AT714)

sc-130245
100 µg/ml
$316.00